{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T04:16:58Z","timestamp":1790223418371,"version":"4.1.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2014,9,13]],"date-time":"2014-09-13T00:00:00Z","timestamp":1410566400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Dermatol Res"],"published-print":{"date-parts":[[2014,11]]},"DOI":"10.1007\/s00403-014-1501-7","type":"journal-article","created":{"date-parts":[[2014,9,12]],"date-time":"2014-09-12T09:04:52Z","timestamp":1410512692000},"page":"843-849","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":42,"title":["TOX expression in different subtypes of cutaneous lymphoma"],"prefix":"10.1007","volume":"306","author":[{"given":"Sohshi","family":"Morimura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Sugaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiraku","family":"Suga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomomitsu","family":"Miyagaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanako","family":"Ohmatsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideki","family":"Fujita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihide","family":"Asano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yayoi","family":"Tada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takafumi","family":"Kadono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinichi","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,9,13]]},"reference":[{"key":"1501_CR1","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1046\/j.1523-1747.2002.19610.x","volume":"119","author":"K Ferenczi","year":"2002","unstructured":"Ferenczi K, Fuhlbrigge RC, Pinkus J et al (2002) Increased CCR4 expression in cutaneous T cell lymphoma. J Invest Dermatol 119:1405\u20131410","journal-title":"J Invest Dermatol"},{"key":"1501_CR2","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1038\/nature03338","volume":"433","author":"X He","year":"2005","unstructured":"He X, He X, Dave VP et al (2005) The zinc finger transcription factor Th-POK regulates CD4 versus CD8 T-cell lineage commitment. Nature 433:826\u2013833","journal-title":"Nature"},{"key":"1501_CR3","doi-asserted-by":"crossref","first-page":"4418","DOI":"10.18632\/oncotarget.2031","volume":"5","author":"Y Huang","year":"2014","unstructured":"Huang Y, Litovinov IV, Wang Y et al (2014) Thymocyte selection-associated high mobility group box gene (TOX) is aberrantly over-expressed in mycosis fungoides and correlates with poor prognosis. Oncotarget 5:4418\u20134425","journal-title":"Oncotarget"},{"key":"1501_CR4","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1158\/1078-0432.CCR-09-2697","volume":"16","author":"T Ishii","year":"2010","unstructured":"Ishii T, Ishida T, Utsunomiya A et al (2010) Defucosylated humanized anti-CCR4 monoclonal antibody KW-0761 as a novel immunotherapeutic agent for adult T-cell leukemia\/lymphoma. Clin Cancer Res 16:1520\u20131531","journal-title":"Clin Cancer Res"},{"key":"1501_CR5","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1067\/mjd.2003.132","volume":"48","author":"T Kakinuma","year":"2003","unstructured":"Kakinuma T, Sugaya M, Nakamura K et al (2003) Thymus and activation-regulated chemokine (TARC\/CCL17) in mycosis fungoides: serum TARC levels reflect the disease activity of mycosis fungoides. J Am Acad Dermatol 48:23\u201330","journal-title":"J Am Acad Dermatol"},{"key":"1501_CR6","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1007\/s10549-011-1502-6","volume":"131","author":"JY Li","year":"2012","unstructured":"Li JY, Ou ZL, Yu SJ et al (2012) The chemokine receptor CCR4 promotes tumor growth and lung metastasis in breast cancer. Breast Cancer Res Treat 131:837\u2013848","journal-title":"Breast Cancer Res Treat"},{"key":"1501_CR7","doi-asserted-by":"crossref","first-page":"3799","DOI":"10.1158\/1078-0432.CCR-14-0307","volume":"20","author":"IV Litovinov","year":"2014","unstructured":"Litovinov IV, Cordeiro B, Huang Y et al (2014) Ectopic expression of cancer-testis antigens in cutaneous T-cell lymphoma patients. Clin Cancer Res 20:3799\u20133808","journal-title":"Clin Cancer Res"},{"key":"1501_CR8","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1038\/jid.2013.461","volume":"134","author":"LY McGirt","year":"2014","unstructured":"McGirt LY, Adams CM, Baerenwald DA et al (2014) miR-223 Regulates cell growth and targets proto-oncogenes in mycosis fungoides\/cutaneous T-cell lymphoma. J Invest Dermatol 134:1101\u20131107","journal-title":"J Invest Dermatol"},{"key":"1501_CR9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jdermsci.2011.07.007","volume":"64","author":"T Miyagaki","year":"2011","unstructured":"Miyagaki T, Sugaya M (2011) Erythrodermic cutaneous T-cell lymphoma: how to differentiate this rare disease from atopic dermatitis. J Dermatol Sci 64:1\u20136","journal-title":"J Dermatol Sci"},{"key":"1501_CR10","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1182\/blood-2007-03-055749","volume":"110","author":"E Olsen","year":"2007","unstructured":"Olsen E, Vonderheid E, Pimpinelli N et al (2007) Revisions to the staging and classification of mycosis fungoides and Sezary syndrome: a proposal of the international society for cutaneous lymphomas (ISCL) and the cutaneous lymphoma task force of the European organization of research and treatment of cancer (EORTC). Blood 110:1713\u20131722","journal-title":"Blood"},{"key":"1501_CR11","doi-asserted-by":"crossref","first-page":"4853","DOI":"10.1182\/blood-2011-01-329656","volume":"118","author":"H Pare","year":"2011","unstructured":"Pare H, Montier Y, Bayry J et al (2011) A CCR4 antagonist combined with vaccines induces antigen-specific CD8\u00a0+\u00a0T cells and tumor immunity against self antigens. Blood 118:4853\u20134862","journal-title":"Blood"},{"key":"1501_CR12","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1111\/j.0022-202X.2004.22326.x","volume":"122","author":"E Poszepczynska-Guign\u00e9","year":"2004","unstructured":"Poszepczynska-Guign\u00e9 E, Schiavon V, D\u2019Incan M et al (2004) CD158k\/KIR3DL2 is a new phenotypic marker of Sezary cells: relevance for the diagnosis and follow-up of Sezary syndrome. J Invest Dermatol 122:820\u2013823","journal-title":"J Invest Dermatol"},{"key":"1501_CR13","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.immuni.2005.01.012","volume":"22","author":"T Sato","year":"2005","unstructured":"Sato T, Ohno S, Hayashi T et al (2005) Dual function of Runx proteins for reactivating CD8 and silencing CD4 at the commitment process into CD8 thymocytes. Immunity 22:317\u2013328","journal-title":"Immunity"},{"key":"1501_CR14","first-page":"7122","volume":"63","author":"MW Su","year":"2003","unstructured":"Su MW, Dorocicz I, Dragowska WH et al (2003) Aberrant expression of T-plastin in Sezary cells. Cancer Res 63:7122\u20137127","journal-title":"Cancer Res"},{"key":"1501_CR15","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.jdermsci.2010.05.005","volume":"59","author":"M Sugaya","year":"2010","unstructured":"Sugaya M (2010) Chemokines and cutaneous lymphomas. J Dermatol Sci 59:81\u201385","journal-title":"J Dermatol Sci"},{"key":"1501_CR16","first-page":"296","volume-title":"WHO classification of tumours of haematopoietic and lymphoid tissues","author":"SH Swerdlow","year":"2008","unstructured":"Swerdlow SH, Campo E, Harris NL et al (2008) WHO classification of tumours of haematopoietic and lymphoid tissues. IARC, Lyon, pp 296\u2013298"},{"key":"1501_CR17","doi-asserted-by":"crossref","first-page":"5578","DOI":"10.1158\/0008-5472.CAN-04-1253","volume":"64","author":"R Doorn van","year":"2004","unstructured":"van Doorn R, Dijkman R, Vermeer MH et al (2004) Aberrant expression of the tyrosine kinase receptor EphA4 and the transcription factor twist in S\u00e9zary syndrome identified by gene expression analysis. Cancer Res 64:5578\u20135586","journal-title":"Cancer Res"},{"key":"1501_CR18","doi-asserted-by":"crossref","first-page":"3369","DOI":"10.1182\/blood.V100.9.3369","volume":"100","author":"F Vega","year":"2002","unstructured":"Vega F, Luthra R, Medeiros LJ et al (2002) Clonal heterogeneity in mycosis fungoides and its relationship to clinical course. Blood 100:3369\u20133373","journal-title":"Blood"},{"key":"1501_CR19","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1038\/ni767","volume":"3","author":"B Wilkinson","year":"2002","unstructured":"Wilkinson B, Chen JY, Han P et al (2002) TOX: an HMG box protein implicated in the regulation of thymocyte selection. Nat Immunol 3:272\u2013280","journal-title":"Nat Immunol"},{"key":"1501_CR20","doi-asserted-by":"crossref","first-page":"3768","DOI":"10.1182\/blood-2004-09-3502","volume":"105","author":"R Willemze","year":"2005","unstructured":"Willemze R, Jaffe ES, Burg G et al (2005) WHO-EORTIC classification for cutaneous lymphoma. Blood 105:3768\u20133785","journal-title":"Blood"},{"key":"1501_CR21","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1038\/jid.2012.13","volume":"132","author":"Y Zhang","year":"2012","unstructured":"Zhang Y, Wang Y, Yu R et al (2012) Molecular markers of early-stage mycosis fungoides. J Invest Dermatol 132:1698\u20131706","journal-title":"J Invest Dermatol"}],"container-title":["Archives of Dermatological Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-014-1501-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00403-014-1501-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-014-1501-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T17:39:56Z","timestamp":1559065196000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00403-014-1501-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9,13]]},"references-count":21,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2014,11]]}},"alternative-id":["1501"],"URL":"https:\/\/doi.org\/10.1007\/s00403-014-1501-7","relation":{},"ISSN":["0340-3696","1432-069X"],"issn-type":[{"value":"0340-3696","type":"print"},{"value":"1432-069X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,9,13]]}}}